All Over-The-Counter — Class II drug recall D-1104-2023
Ongoing recall by Inmar Supply Chain Solutions, LLC, reported 2023-08-30. CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to un
| Recall number | D-1104-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Recalling firm | Inmar Supply Chain Solutions, LLC, Arlington, TX, United States |
| Recall initiated | 2023-08-14 |
| Classified | 2023-08-24 |
| Reported by FDA | 2023-08-30 |
| Reason classes | labeling, cgmp |
Product
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
Reason for recall
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1104-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.